Streetbeat News

Equity Actions

PSN

Parsons Corporation has updated its stock repurchase program, now authorizing up to $100 million in buybacks and eliminating the previous quarterly cap of $25 million. This move indicates the company's confidence in its financial health and a commitment to returning value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:49 pm

PSN

Parsons Corporation announced the full exercise of a $100M option to purchase additional notes in its private offering of 2.625% Convertible Senior Notes due in 2029, raising the total to $800M.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:14 pm

AER

AerCap has announced a new share repurchase program, authorizing the repurchase of up to $500 million of its ordinary shares through September 30, 2024. This move is aimed at returning value to shareholders and reflects the company's confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:10 pm

TAC

TransAlta announced an enhanced common share repurchase program for 2024, planning to buy back up to C$150M of its shares. This move is aimed at returning value to shareholders and reflects the company's confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:06 pm

PEN

Penumbra (NYSE:PEN) has been analyzed by 6 analysts, showing a mix of bullish to indifferent sentiments. The average 12-month price target is $277.17, up from $259.50, with actions ranging from lowering to raising ratings and price targets by firms like JP Morgan and RBC Capital. Penumbra, a medical device manufacturer, showed a revenue growth of 26.8% as of September 30, 2023, but lags in net margin and ROE compared to industry averages. Its debt-to-equity ratio is below industry average, indicating less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 12:00 pm

HUN

Four analysts have recently updated their ratings and price targets for Huntsman (NYSE:HUN), showing a mix of bullish to bearish sentiments. The average 12-month price target has been raised to $27.25, up 7.58% from the previous $25.33. Analyst actions include both upgrades and downgrades, with price targets ranging from $20.00 to $32.00. Huntsman's financial performance shows challenges in revenue growth and efficiency metrics, but a strong net margin and conservative debt management.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 12:00 pm

IRTC

Analyst ratings for iRhythm Technologies (NASDAQ:IRTC) show a bullish consensus with all 5 analysts giving positive ratings. The 12-month price target has increased by 9.98% to an average of $126.2. The company, specializing in cardiac arrhythmia diagnosis through wearable technology, has seen a revenue growth of 19.96% as of September 30, 2023, but lags in profitability and efficiency metrics compared to industry averages.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 12:00 pm

BLMN

Bloomin' Brands has announced a new $350 million share repurchase program, set to expire on August 13, 2025. This move indicates the company's confidence in its financial health and a commitment to returning value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 11:51 am

GIB

CGI plans to repurchase 1.67 million of its shares for a total of $250 million, using its cash reserves for the transaction. This move indicates the company's confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 11:35 am

KIND

Nextdoor announced an increase in its share repurchase authorization by $150M, bringing the total authorization to $250M. The program has been extended until March 31, 2026.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 11:13 am